drugset / Trial / NCT01333904
Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to establish single and multiple dose safety in healthy subjects and subjects with mild chronic pulmonary obstructive disease (COPD). In addition, the study will evaluate preliminary proof of concept endpoints in COPD subjects such as biomarkers in sputum and mucociliary clearance.
Timeline
- Start
- 2011-02
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PUR118 | Unknown | — | Inhaled |